No profile data available.
Koru Medical Systems, Inc. (KRMD) is a healthcare company in the IV treatment equipment industry, based in Mahwah, United States, with about 73 full-time employees.
It reported revenue of $33.65 million for fiscal year 2024, up 18.0% from fiscal year 2023, and net income of -$6.07 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $10.40 million, up 27.2% from a year before. United States was its largest region in fiscal year 2025, with 74% of revenue. Its market capitalization was $138.98 million as of October 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 5, 2026.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
Koru Medical Systems reported $33.65 million in revenue for fiscal year 2024, up 18.0% from $28.52 million in fiscal year 2023. In Q3 2025 revenue was $10.40 million.
United States: 74% of revenue by region in fiscal year 2025, followed by International (26%).
$138.98 million as of October 5, 2026.
Listed companies of a similar size in the same industry (IV treatment equipment) include CorMedix Inc. (CRMD), Delcath Systems, Inc. (DCTH), TriSalus Life Sciences, Inc. (TLSI), RenovoRx, Inc. (RNXT).